Perioperative diagnosis of cystosarcoma phyllodes of the breast may be enhanced by MIB-1 index

被引:18
|
作者
Ridgway, PF
Jacklin, RK
Ziprin, P
Harbin, L
Peck, DH
Darzi, AW
Rajan, PB
机构
[1] St Marys Hosp, Imperial Coll Fac Med, Dept Surg Oncol & Technol, London W2 1NY, England
[2] St Marys Hosp, Imperial Coll Fac Med, Dept Pathol, London W2 1NY, England
关键词
phyllodes; Ki-67; MIB-1; fibroadenoma; breast; diagnosis;
D O I
10.1016/j.jss.2004.07.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The recurring theme in cystosarcoma phyllodes (CSP) is one of underdiagnosis by pathologists and undertreatment by surgeons. Major areas of investigation relating to the diagnosis of CSP center on accurate preoperative diagnosis, elucidating the relevance of histological classification with respect to outcome, and identifying novel markers to reliably differentiate CSP from fibroadenoma (FA). Materials and methods. Fifteen CSP and 7 cellular FA controls (where the preoperative diagnosis was unclear) were retrospectively investigated. Preoperative histological and radiological investigations were reviewed for efficacy. The ability of MIB-1 antibody to differentiate the two fibroepithelial lesions was investigated using immunohistochemical estimation of the MIB-1 index. Results and discussion. Preoperative core biopsy had a sensitivity of 75% but was carried out in only 23% of cases. Fine needle aspiration cytology and radiological assessment were not efficacious in preoperative diagnosis. Proliferative activity (MIB-1 indices) was significantly higher in CSP than in a selected population of FA where there was preoperative diagnostic uncertainty (P < 0.0001). Indices were also able to determine CSP subclassification. This suggests MlB-1 as a constructive adjunctive investigation when evaluating histological features to differentiate CSP from FA in difficult cases. Conclusions. The use of MlB-1 may increase the sensitivity of preoperative core biopsy diagnosis, offering more effective surgical planning and decreasing immediate reoperation rates. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [21] Ki67/MIB-1 Proliferation index in meningiomas
    Brodhun, M.
    Thomas, M.
    Lehrmann, K.
    Patt, S.
    HISTOPATHOLOGY, 2008, 53 : 313 - 314
  • [22] MIB-1 proliferative index is increased in microscopic colitis.
    Treanor, D
    Morgan, S
    O'Donoghue, D
    Sheahan, K
    JOURNAL OF PATHOLOGY, 2001, 193 : 23A - 23A
  • [23] Practical value of MIB-1 index in predicting behavior of astrocytomas
    Ambroise, M. Moses
    Khosla, Charu
    Ghosh, Mitra
    Mallikarjuna, V. S.
    Annapurneswari, S.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (03) : 520 - 525
  • [24] Craniopharyngioma with rapid regrowth - Role of MIB-1 labeling index
    Anegawa, S
    Hayashi, T
    Nakagawa, S
    Furukawa, Y
    Tomokiyo, M
    NEUROLOGICAL SURGERY, 2001, 29 (08): : 727 - 733
  • [25] Prognostic value of the MIB-1 labeling index for central neurocytomas
    Rades, D
    Schild, SE
    Fehlauer, F
    NEUROLOGY, 2004, 62 (06) : 987 - 989
  • [26] MIB-1 proliferative index is increased in microscopic colitis.
    Treanor, D
    Morgan, S
    O'Donoghue, D
    Sheahan, K
    MODERN PATHOLOGY, 2001, 14 (01) : 97A - 97A
  • [27] MIB-1 proliferative index is increased in microscopic colitis.
    Treanor, D
    Morgan, S
    O'Donoghue, D
    Sheahan, K
    LABORATORY INVESTIGATION, 2001, 81 (01) : 97A - 97A
  • [28] Histologic grade, MIB-1 labeling index and MRI in oligodendrogliomas
    Coons, SW
    Ashby, LS
    Heiserman, JE
    Schneider, AG
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 472 - 472
  • [29] The clinical significance of MIB-1 labeling index in pituitary adenomas
    Chacko, Geeta
    Chacko, Ari G.
    Kovacs, Kalman
    Scheithauer, Bernd W.
    Mani, Sunithi
    Muliyil, J. P.
    Seshadri, M. S.
    PITUITARY, 2010, 13 (04) : 337 - 344
  • [30] Proliferation index determined by MIB-1 and recurrence in endometrial cancer
    Geisler, JP
    Wiemann, MC
    Zhou, Z
    Miller, GA
    Geisler, HE
    GYNECOLOGIC ONCOLOGY, 1996, 61 (03) : 373 - 377